Cargando…
Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755864/ https://www.ncbi.nlm.nih.gov/pubmed/31502471 http://dx.doi.org/10.1177/1073274819874122 |
_version_ | 1783453310517248000 |
---|---|
author | Steponaviciene, Laura Vincerzevskiene, Ieva Briediene, Ruta Urbonas, Vincas Vanseviciute-Petkeviciene, Rasa Smailyte, Giedre |
author_facet | Steponaviciene, Laura Vincerzevskiene, Ieva Briediene, Ruta Urbonas, Vincas Vanseviciute-Petkeviciene, Rasa Smailyte, Giedre |
author_sort | Steponaviciene, Laura |
collection | PubMed |
description | OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed. RESULTS: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant. CONCLUSIONS: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries. |
format | Online Article Text |
id | pubmed-6755864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-67558642019-09-27 Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening Steponaviciene, Laura Vincerzevskiene, Ieva Briediene, Ruta Urbonas, Vincas Vanseviciute-Petkeviciene, Rasa Smailyte, Giedre Cancer Control Original Research Paper OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed. RESULTS: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant. CONCLUSIONS: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries. SAGE Publications 2019-09-10 /pmc/articles/PMC6755864/ /pubmed/31502471 http://dx.doi.org/10.1177/1073274819874122 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Paper Steponaviciene, Laura Vincerzevskiene, Ieva Briediene, Ruta Urbonas, Vincas Vanseviciute-Petkeviciene, Rasa Smailyte, Giedre Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening |
title | Breast Cancer Screening Program in Lithuania: Interval Cancers and
Program Sensitivity After 7 Years of Mammography Screening |
title_full | Breast Cancer Screening Program in Lithuania: Interval Cancers and
Program Sensitivity After 7 Years of Mammography Screening |
title_fullStr | Breast Cancer Screening Program in Lithuania: Interval Cancers and
Program Sensitivity After 7 Years of Mammography Screening |
title_full_unstemmed | Breast Cancer Screening Program in Lithuania: Interval Cancers and
Program Sensitivity After 7 Years of Mammography Screening |
title_short | Breast Cancer Screening Program in Lithuania: Interval Cancers and
Program Sensitivity After 7 Years of Mammography Screening |
title_sort | breast cancer screening program in lithuania: interval cancers and
program sensitivity after 7 years of mammography screening |
topic | Original Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755864/ https://www.ncbi.nlm.nih.gov/pubmed/31502471 http://dx.doi.org/10.1177/1073274819874122 |
work_keys_str_mv | AT steponavicienelaura breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening AT vincerzevskieneieva breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening AT briedieneruta breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening AT urbonasvincas breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening AT vanseviciutepetkevicienerasa breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening AT smailytegiedre breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening |